Gunter von Minckwitz, MD, PhD
Articles
Bevacizumab Plus Chemo in Early Stage HER2-Negative Breast Cancer
February 13th 2012Dr. Gunter von Minckwitz discusses the recent paper he authored that showed that bevacizumab in addition to neoadjuvant chemotherapy significantly increased the rate of pathological complete response in patients with early stage HER2-negative breast cancer.
What Is the Current Standard of Care for Anti-HER2 Neoadjuvant Therapy in Breast Cancer?
January 16th 2012This article provides a comprehensive summary of the knowledge gained from recent neoadjuvant trials conducted with agents targeting HER2, and will put them into perspective with current treatment recommendations from American and European guidelines.
Latest Updated Articles
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: August 26th 2011 | Updated: November 17th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: July 26th 2016 | Updated: November 17th 2024
Pancreatic Mass Found in 43-Year-Old Patient
Published: July 31st 2012 | Updated: November 17th 2024
NSCLC Patient Develops Fever and Rash Following Treatment for Brain Metastases
